Indivior Share Price (INDV)

Find Your Broker

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Indivior	LSE:INDV	London	Ordinary Share	GB00BRS65X63	ORD USD0.10

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-1.40p	-1.16%	119.35p	642,364	14:26:17

Bid Price		Offer Price	High Price	Low Price	Open Price
119.30p		119.50p	120.95p	115.75p	118.30p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	809.24	101.43	5.92	19.2	869.2

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Venn Life (VENN), Port Erin (PEBI)

Indivior (INDV) Latest News

Indivior News

Date	Time	Source	Headline
22/1/2019	15:51	UKREG	Indivior PLC Holding(s) in Company
21/1/2019	07:00	UKREG	Indivior PLC Notice of Results
11/1/2019	10:28	ALNCF	Alliance News Flash Headline
09/1/2019	15:07	UKREG	Indivior PLC Holding(s) in Company
07/1/2019	12:30	PRNUS	DURECT Corporation Provides Corporate Update
03/1/2019	08:44	UKREG	Indivior PLC Holding(s) in Company
20/12/2018	12:30	PRNUS	Aquestive Therapeutics Provides End of Year Business Update, Including..
20/12/2018	08:53	ALNC	Indivior Publishes Design For New Study Of Addiction Drug Sublocade
20/12/2018	07:00	UKREG	Indivior PLC Indivior publishes real-world RECOVER study design
19/12/2018	13:00	PRNUS	Commercial Launch Plans Announced for PERSERIS™ (risperidone)..

More Indivior News

Indivior Takeover Rumours

Indivior (INDV) Share Charts

1 Year Indivior Chart

1 Month Indivior Chart

Intraday Indivior Chart

Indivior (INDV) Discussions and Chat

Indivior Forums and Chat

Date	Time	Title	Posts
21/1/2019	16:39	RB. de-merger	507
30/12/2018	21:04	INDIVIOR THE PILL WITH NO CHEERS OR BEERS	246
31/7/2018	12:45	Indivior (INDV) IP Battle Status	-
28/7/2018	13:16	Indivior (INDV) One to Watch on Monday	2
14/5/2018	12:52	Indivior (INDV) Settles Legal Patent Battle	-

Add a New Thread

Indivior (INDV) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
14:26:17	119.55	785	938.47	O
14:26:17	119.35	346	412.95	AT
14:26:17	119.55	1,741	2,081.37	AT
14:26:17	119.55	1,829	2,186.57	AT
14:25:02	119.60	416	497.54	AT

View all Indivior trades in real-time

Indivior (INDV) Top Chat Posts

Date	Subject
23/1/2019 08:20	Indivior Daily Update: Indivior is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker INDV. The last closing price for Indivior was 120.75p. Indivior has a 4 week average price of 102.40p and a 12 week average price of 75.48p. The 1 year high share price is 504.60p while the 1 year low share price is currently 75.48p. There are currently 728,306,837 shares in issue and the average daily traded volume is 2,068,719 shares. The market capitalisation of Indivior is £875,060,664.66. Read Full Thread Reply
23/11/2018 08:00	pwhite73: RNS out but it is worthless. Investors should expect a string of vacuous RNS announcements over the next few months to try and mitigate against the US court decision and boost a flagging share price. Read Full Thread Follow Reply
21/11/2018 08:05	pwhite73: PWhite731 Oct '18 - 22:32 - 452 of 491 Edit 0 0 0 The writing is on the wall for this company. The share price was trading at 490p in June 2018. There are a number of problems here. 1. The opioid addiction market is too competitive and relatively easy to enter. 2. The injunction against Dr Reddy is only temporary. 3. Donald Trump and the State Department are soon to announce their own nationwide programme to combat opioid addiction in the US. The shares can be traded as it bounces off the bottom but because of the share price you need lots of upfront capital to make any decent money. Those who think the share price is about to mount a recovery are mistaken. When the next set of adverse news is released it will plunge again Read Full Thread Follow Reply
01/10/2018 22:32	pwhite73: The writing is on the wall for this company. The share price was trading at 490p in June 2018. There are a number of problems here. 1. The opioid addiction market is too competitive and relatively easy to enter. 2. The injunction against Dr Reddy is only temporary. 3. Donald Trump and the State Department are soon to announce their own nationwide programme to combat opioid addiction in the US. The shares can be traded as it bounces off the bottom but because of the share price you need lots of upfront capital to make any decent money. Those who think the share price is about to mount a recovery are mistaken. When the next set of adverse news is released it will plunge again. Read Full Thread Follow Reply
21/8/2018 08:44	naed: Very quite here......share price constantly loosing value? Read Full Thread Follow Reply
12/7/2018 15:03	steeplejack: Good recovery today,hope this presages a favourable court review. Plus... Indivior got a boost as Bank of America Merrill Lynch upgraded the stock to 'buy' following recent share price weakness. Read Full Thread Follow Reply
11/7/2018 09:15	mj19: http://www.cityam.com/289071/indivior-share-price-dives-wake-us-market-competition Read Full Thread Follow Reply
16/6/2018 11:58	kazoom: I am new to Indivior so apologies if this doesn't make sense - please feel free to correct me ;-) When I read "So Dr Reddy is really interested in testing punitive damages! I do wonder." I wonder if Dr Reddy are actually engaged in some Trump style bargaining. I note here Https://www.investegate.co.uk/indivior-plc--indv-/rns/indivior-settlement-with-par-pharmaceutical/201805140700088858N/ (14-may) that INDV settled with PAR phara and that Par get the ability to sell the generic from Jan 2023 Maybe Reddy are angling for a similar settlement? Also if Par don't have the rights until 2023 - why would we expect the courts to grant a later comer like Reddy earlier access to the market? On that basis (and of course it could be nonsense) it seems to be that the outcome is likely to be much better than Friday's share price movement would suggest. Any thoughts? Read Full Thread Follow Reply
02/5/2018 13:40	sarkasm: http://uk.advfn.com/stock-market/london/indivior-INDV/share-news/Indivior-PLC-1st-Quarter-Results/77315882 Read Full Thread Follow Reply
01/11/2017 11:47	gregmorg: Yup, as you say, who knows with this one! Good thing is it is increasingly looking a less dangerous/more secure company. So after the 2nd November we then roll on to that other tester of our investors steel --on the 14th. Will see how that coding scenario has developed . It could be the stock starts to put the days of serious uncertainty behind it. Revenues are looking good and growing very respectably. But what about the veins!~! Thinking of patience(or apathy!) I have been a little puzzled by GSK's share price performance in recent time but am hoping this baptism of fire gears up/fires up the new CEO. OR what! As for my other pharma, IMB, I do wish, Steeplejack, I had more noted your disposal some months back and so questioned my own rationale. Good call. Now I am left waiting for Vaping to kick in! Hopefully this is made less painless by a continued good stream of dividends. Let's see what tomorrow brings on IND . Unfortunately I cannot listen in to the live investors meeting as I have some silly cross country trail commitment. Hopefully I can listen in later in the day. Read Full Thread Follow Reply
31/10/2017 21:06	gregmorg: Steeplejack. I understand the Committee vote at the end was 18 for and one against.The latter was on the basis of this was nothing new! This, I hasten to add, is purely my understanding. I did say this Committee is advisory but it does look as if the recommendation to the FDA is going our way. A few concerns were raised re the results of the 300mg doses( as opposed to the 100mg) and a few small issues that resulted, but this does not appear to have affected the outcome. So possibly it is looking OK!. We both have experiences of erratic share price performance across the financial reporting period so its important to maintain the longer view. Read Full Thread Follow Reply

Indivior share price data is direct from the London Stock Exchange

Your Recent History

LSE

INDV

Indivior

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190123 14:43:21